RT-PCR

Reverse Transcription Polymerase Chain Reaction (RT-PCR) is a sensitive and specific technique used to detect and amplify RNA sequences.  The procedure is a two-step process: first, an enzyme called reverse transcriptase converts the RNA into a stable DNA copy (cDNA). Second, standard PCR is used to create billions of copies of that specific cDNA sequence. This amplification makes it possible to detect even minute quantities of a specific RNA molecule, making RT-PCR an essential tool for confirming the identity of RNA therapeutics, analyzing gene expression, and detecting RNA viruses.

Legacy: Before RT-PCR, RNA analysis was primarily done using Northern Blotting, a slow, non-quantitative method that required large amounts of RNA.

Current Standard: Reverse Transcription Quantitative Real-Time PCR (RT-qPCR) remains the established platform for RNA detection and quantification in most laboratories. However, Digital PCR (dPCR) is increasingly used as an orthogonal or primary method for absolute quantification of RNA or cDNA copies without the need for a standard curve.

Future: Continued improvements in dPCR automation and integration into GMP/QC workflows are expected, along with broader use of Next-Generation Sequencing (NGS) for comprehensive transcript analysis and impurity profiling.

The technique works like a molecular photocopier that first needs to convert the original document (RNA) into a standard paper format (DNA) before it can make copies.

Step 1: Reverse Transcription (RNA → cDNA):

The process begins with the RNA sample.

Reverse Transcriptase synthesizes a single strand of complementary DNA (cDNA) using the RNA as a template. This requires a primer to start the reaction.

Step 2: Polymerase Chain Reaction (PCR Amplification):

The newly created cDNA serves as the template for standard PCR. This process is a cycle of three temperature steps:

Denaturation (~95°C): The cDNA strands are separated.

Annealing (~55-65°C): Specific primers bind to the target cDNA sequence.

Extension (~72°C): A DNA polymerase enzyme copies the cDNA sequence.

This cycle is repeated 30-40 times, resulting in an exponential amplification of the target sequence.

For basic RT-PCR: The output is visualized on an agarose gel. A DNA band of the expected size indicates the target RNA was present.

For RT-qPCR (most common): The output is an amplification plot (fluorescence vs. cycle). The key metric is the Cycle threshold (Ct)—the cycle number where the fluorescence signal becomes detectable.

Interpretation: The presence of a signal with a Ct value below a defined cutoff confirms the presence of the target RNA. A lower Ct value indicates a higher starting amount of RNA.

Extreme Sensitivity: Capable of detecting as little as a single copy of an RNA molecule.

High Specificity: The use of target-specific primers ensures only the RNA of interest is amplified.

Speed: RT-qPCR provides results in a matter of hours.

Quantitative (as RT-qPCR): Allows for precise quantification of RNA levels.

Susceptible to Contamination: The assay is vulnerable to false positives from contaminating DNA or RNA in the lab environment.

Requires High-Quality RNA: RNA is inherently unstable; the assay's success depends on careful sample handling to prevent degradation.

Prone to Inhibition: Substances in the sample matrix can inhibit the enzymes, leading to inaccurate results or false negatives.

Specificity: The assay must be proven to amplify only the target RNA and not related sequences.

Limit of Detection (LOD): The lowest amount of RNA that can be reliably detected must be established.

Controls: The assay is invalid without proper controls, including:

No Template Control (NTC): To detect contamination.

No RT Control (-RT): To ensure the signal comes from RNA, not from any contaminating DNA in the sample.

Reference Materials: A highly purified and well-characterized RNA transcript of the target sequence is used as a positive control and, for RT-qPCR, to generate a standard curve for quantification.

Primers & Probes: The DNA sequences of the primers and probes are critical parameters that must be carefully designed and controlled.

mRNA Therapeutics: A fundamental test for confirming the identity of the drug substance.

Cell & Gene Therapy: Used for viral safety testing, measuring vector copy number, and assessing transgene expression as a potency readout.

Medical Diagnostics: The basis for most modern diagnostic tests for RNA viruses, including COVID-19, HIV, and influenza.